For example, leuprolide is a peptide drug that targets the gonadotropin-releasing hormone receptor, and it is used in the treatment of prostate cancer, while goserelin is a clinically available synthetic peptide drug for treating breast and prostate cancers [7]. This evidence concerns the gene GNRHR and prostate carcinoma.